Adimmune Corporation develops, manufactures, and distributes human vaccines in Taiwan. The company’s products include AdimFlu-S, tetanus toxoid alum precipitated products, and Japanese encephalitis vaccines, as well as CMO for filling. It also offers antigen bulk influenza vaccines on contract manufacturing basis; and distributes Tuberculin PPD products. In addition, the company provides seasonal flu vaccines; fill and finish services; product testing and analysis of quality of vaccines and biological products, as well as other tests; quality assurance courses, comprising introductory courses on GMP-related subjects to schools and industries; and consulting services, such as planning, design, construction, validation, and project management of biological product plant. Further, it rents cold storage facilities. The company was formerly known as Kuo Kwang Serum and Vaccine Manufacture Co., Ltd. and changed its name to Adimmune Corporation in 2001. Adimmune Corporation was founded in 1965 and is based in Taichung, Taiwan.
adimmune corp (4142:Taiwan)
No.3, Section 1, Tanxing Road
Phone: 886 4 2538 1220
Fax: 886 4 2539 5133www.adimmune.com.tw
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content.
|No competitor information is available for 4142.|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|
Sponsored Financial Commentaries
To contact ADIMMUNE CORP, please visit www.adimmune.com.tw. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.